Director Douglas A. Roeder not standing for re-election at Tandem's 2022 Annual Meeting

TANDEM DIABETES CARE INC

Douglas A. Roeder notified the company on March 11, 2022, of his decision not to stand for re-election.
Roeder has served on the Board since May 2009; his term as Class III director ends at the 2022 Annual Meeting.
The departure is not due to any disagreement with the company on operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Douglas A. Roeder

Director

TNDM · TANDEM DIABETES CARE INC

Filed: March 15, 2022, 7:59 PM ET

On March 11, 2022, Douglas A. Roeder, notified the Company of his decision not to stand for re-election at the Company’s 2022 Annual Meeting of Stockholders

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Douglas A. Roeder departed as Director at TANDEM DIABETES CARE INC.

Action: not stand for re-election
Role: Director

Exact text from the filing

On March 11, 2022, Douglas A. Roeder, notified the Company of his decision not to stand for re-election at the Company’s 2022 Annual Meeting of Stockholders

View on SEC.gov

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR

accession 0001438133-22-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.